Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy.
作者信息
Ho Carolyn Y
机构信息
Cardiovascular Genetics Center, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
出版信息
Circulation. 2010 Dec 7;122(23):2430-40; discussion 2440. doi: 10.1161/CIRCULATIONAHA.110.978924.
Abstract
摘要
相似文献
1
Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy.遗传学与临床转归：改善肥厚型心肌病的治疗
Circulation. 2010 Dec 7;122(23):2430-40; discussion 2440. doi: 10.1161/CIRCULATIONAHA.110.978924.
2
Current management of hypertrophic cardiomyopathy.肥厚型心肌病的当前管理
Hosp Med. 2001 Feb;62(2):79-82. doi: 10.12968/hosp.2001.62.2.1524.
3
Can genetic testing improve our aim in hypertrophic cardiomyopathy?基因检测能否改善我们对肥厚型心肌病的治疗目标？
Circ Res. 2010 May 14;106(9):1446-8. doi: 10.1161/CIRCRESAHA.110.220343.
4
Guidelines for the diagnosis and management of hypertrophic cardiomyopathy.肥厚型心肌病诊断与管理指南。
Heart Lung Circ. 2007 Feb;16(1):16-8. doi: 10.1016/j.hlc.2006.10.020. Epub 2006 Dec 26.
5
Genetics of hypertrophic cardiomyopathy: what is the next step?肥厚型心肌病的遗传学：下一步是什么？
Heart. 2020 Sep;106(17):1291-1292. doi: 10.1136/heartjnl-2020-317043. Epub 2020 Jun 16.
6
Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.肥厚型心肌病的遗传学：对临床实践的既定和新出现的影响。
Eur Heart J. 2024 Aug 9;45(30):2727-2734. doi: 10.1093/eurheartj/ehae421.
7
[The cutting-edge of medicine; genetic diagnosis for hypertrophic cardiomyopathy: how to promote its clinical application].[医学前沿；肥厚型心肌病的基因诊断：如何促进其临床应用]
Nihon Naika Gakkai Zasshi. 2013 May 10;102(5):1233-42. doi: 10.2169/naika.102.1233.
8
Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies.遗传性肥厚型和扩张型心肌病基因检测的临床应用
Cardiovasc Ultrasound. 2008 Dec 19;6:62. doi: 10.1186/1476-7120-6-62.
9
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.儿童一级亲属肥厚型心肌病临床筛查的检出率。
Circulation. 2019 Jul 16;140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22.
10
[The contribution of molecular genetics to clinical cardiology: the example of hypertrophic cardiomyopathy].[分子遗传学对临床心脏病学的贡献：以肥厚型心肌病为例]
Rev Med Suisse. 2005 May 25;1(21):1448, 1450, 1452-3.
引用本文的文献
1
Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy.综述：马伐卡坦和阿非卡坦用于肥厚型心肌病的研究
Biomedicines. 2025 Jul 1;13(7):1619. doi: 10.3390/biomedicines13071619.
2
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
3
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.肥厚型心肌病与心肌受累的贮积病的比较。
Int J Mol Sci. 2023 Aug 26;24(17):13239. doi: 10.3390/ijms241713239.
4
Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis.心房颤动患者伴或不伴肥厚型心肌病的导管消融治疗：系统评价和荟萃分析。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad256.
5
Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TPM1 variant S215L.肥厚型心肌病相关TPM1变体S215L的致病机制。
PNAS Nexus. 2023 Jan 21;2(3):pgad011. doi: 10.1093/pnasnexus/pgad011. eCollection 2023 Mar.
6
Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.泰国临床遗传学服务中肥厚型和扩张型心肌病的基因组学发现。
PLoS One. 2022 Sep 27;17(9):e0267770. doi: 10.1371/journal.pone.0267770. eCollection 2022.
7
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes.早发性心房颤动患者的死亡率与心肌病和心律失常基因中的罕见变异有关。
JAMA Cardiol. 2022 Jul 1;7(7):733-741. doi: 10.1001/jamacardio.2022.0810.
8
Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management.了解家族性肥厚型心肌病的遗传和分子基础及其治疗的基因治疗当前趋势。
Cureus. 2021 Aug 29;13(8):e17548. doi: 10.7759/cureus.17548. eCollection 2021 Aug.
9
Genetic Testing in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的基因检测。
Int J Mol Sci. 2021 Sep 27;22(19):10401. doi: 10.3390/ijms221910401.
10
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure.心肌病的遗传学：对心力衰竭的临床及机制影响
Korean Circ J. 2021 Oct;51(10):797-836. doi: 10.4070/kcj.2021.0154. Epub 2021 Jul 22.
本文引用的文献
1
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.心肌纤维化作为肥厚型心肌病的早期表现。
N Engl J Med. 2010 Aug 5;363(6):552-63. doi: 10.1056/NEJMoa1002659.
2
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.肥厚型心肌病小鼠的心脏纤维化是由非心肌细胞增殖介导的，需要 TGF-β。
J Clin Invest. 2010 Oct;120(10):3520-9. doi: 10.1172/JCI42028. Epub 2010 Sep 1.
3
Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy.短篇交流：肌球蛋白结合蛋白 C Arg502Trp 突变：肥厚型心肌病的常见病因。
Circ Res. 2010 May 14;106(9):1549-52. doi: 10.1161/CIRCRESAHA.109.216291. Epub 2010 Apr 8.
4
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.与三肌节蛋白基因突变相关的肥厚型心肌病的临床特征和结局。
J Am Coll Cardiol. 2010 Apr 6;55(14):1444-53. doi: 10.1016/j.jacc.2009.11.062.
5
Genetics of hypertrophic cardiomyopathy.肥厚型心肌病的遗传学。
Curr Opin Cardiol. 2010 May;25(3):205-9. doi: 10.1097/HCO.0b013e3283375698.
6
Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.超声心动图应变成像评估肥厚型心肌病肌节突变的早期和晚期后果。
Circ Cardiovasc Genet. 2009 Aug;2(4):314-21. doi: 10.1161/CIRCGENETICS.109.862128. Epub 2009 Jun 19.
7
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.肥厚型心肌病肌球蛋白结合蛋白 C 基因突变携带者心脏性猝死风险分层的检出率：以预测性筛查为重点。
Eur Heart J. 2010 Apr;31(7):842-8. doi: 10.1093/eurheartj/ehp539. Epub 2009 Dec 16.
8
Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection.基于过滤器的亚基因组杂交捕获可实现重测序和拷贝数检测。
Nat Methods. 2009 Jul;6(7):507-10. doi: 10.1038/nmeth.1343. Epub 2009 Jun 21.
9
Genomic copy number variation, human health, and disease.基因组拷贝数变异、人类健康与疾病。
Lancet. 2009 Jul 25;374(9686):340-50. doi: 10.1016/S0140-6736(09)60249-X. Epub 2009 Jun 15.
10
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.LAMP2 型心肌病的临床结局与表型表达
JAMA. 2009 Mar 25;301(12):1253-9. doi: 10.1001/jama.2009.371.
Zotero 插件